AlphaYouDB
Congress trade
Rep. Donald Beyer (D-VA) bought $1K-$15K of Regeneron Pharmaceuticals, Inc. (REGN) stock
Donald Beyer, U.S. Representative (D-VA), disclosed a purchase of Regeneron Pharmaceuticals, Inc. (REGN) stock worth $1K-$15K in a STOCK Act filing on Jul 4, 2021.
The trade happened on Jun 17, 2021, 17 days before it was made public.
REGN has moved +37.2% since the trade date, from $536.01 to $735.20 (Oct 2, 2026 close).
- Traded
- Jun 17, 2021
- Disclosed
- Jul 4, 2021
- Filing delay
- 17 days
- Price since
- +37.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (12)
- SellAAPL$1K-$15KJul 4, 2021
- BuyASML$1K-$15KJul 4, 2021
- BuyBRK.B$1K-$15KJul 4, 2021
- BuyBRK.B$1K-$15KJul 4, 2021
- SellDAIUF$1K-$15KJul 4, 2021
- SellECL$1K-$15KJul 4, 2021
- BuyFNV$1K-$15KJul 4, 2021
- BuyGOOG$1K-$15KJul 4, 2021
- SellMSFT$1K-$15KJul 4, 2021
- BuyNEE$1K-$15KJul 4, 2021
- SellNEE$1K-$15KJul 4, 2021
- SellTDOC$1K-$15KJul 4, 2021
More REGN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.